Preferred Label : Bendamustine/Rituximab Followed by High-dose Cytarabine/Rituximab Regimen;
NCIt synonyms : Bendamustine/Rituximab Followed by High-dose Cytarabine/Rituximab; Bendamustine-Rituximab Followed by High-dose Cytarabine-Rituximab; Bendamustine/Rituxan Followed by HiDAC/Rituxan;
NCIt definition : A regimen consisting of bendamustine and rituximab followed by high-dose cytarabine
and rituximab that can be used for the treatment of mantle cell lymphoma (MCL).;
Origin ID : C210784;
chemotherapy_regimen_has_component
concept_is_in_subset